Aethlon Medical

Aethlon Medical develops immunotherapeutic technologies to combat cancer and life-threatening infectious disease, anchored by the Aethlon Hemopurifier, a first-in-class clinical-stage therapeutic filtration device designed for the rapid depletion of cancer-promoting exosomes and circulating viruses from biologic fluids. The Hemopurifier holds U.S. FDA Breakthrough Device designations in both oncology and infectious disease. The company is pursuing clinical evaluation of the device in oncology settings and viral-infection indications, with a strategic focus on its Hemopurifier program.